EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 / Numéro 8-9 (Août–Septembre 2018) Med Sci (Paris), 34 8-9 (2018) 693-700 Références
Open Access
Numéro
Med Sci (Paris)
Volume 34, Numéro 8-9, Août–Septembre 2018
Les Cahiers de Myologie
Page(s) 693 - 700
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20183408016
Publié en ligne 19 septembre 2018
  1. Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J 2018 ;12 : 26–32. [CrossRef] [PubMed] [Google Scholar]
  2. Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology 2015 ; 479-480 : 672–686. [CrossRef] [PubMed] [Google Scholar]
  3. Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012 ; 3. [Google Scholar]
  4. European Association for the Study of the Liver. Electronic address eee, European association for the study of the L. EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017 ; 67 : 370–398. [CrossRef] [PubMed] [Google Scholar]
  5. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 2010 ; 58 : 258–266. [CrossRef] [PubMed] [Google Scholar]
  6. Chang MH, Chen DS. Prevention of hepatitis B. Cold Spring Harb Perspect Med 2015 ; 5 : a021493. [CrossRef] [Google Scholar]
  7. Rijckborst V, Janssen HL. The role of interferon in hepatitis B therapy. Curr Hepat Rep 2010 ; 9 : 231–238. [CrossRef] [PubMed] [Google Scholar]
  8. Zlotnick A, Venkatakrishnan B, Tan Z, et al. Core protein : a pleiotropic keystone in the HBV lifecycle. Antiviral Res 2015 ; 121 : 82–93. [CrossRef] [PubMed] [Google Scholar]
  9. Chu TH, Liou AT, Su PY, et al. Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein. J Virol 2014 ; 88 : 2530–2543. [CrossRef] [PubMed] [Google Scholar]
  10. Watts NR, Conway JF, Cheng N, et al. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 2002 ; 21 : 876–884. [CrossRef] [PubMed] [Google Scholar]
  11. Diab A, Foca A, Zoulim F, et al. The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle : Implications for the development of HBc-targeting antivirals. Antiviral Res 2018 ; 149 : 211–220. [CrossRef] [PubMed] [Google Scholar]
  12. Ricco R, Kanduc D. Hepatitis B virus and Homo sapiens proteome-wide analysis : a profusion of viral peptide overlaps in neuron-specific human proteins. Biologics 2010 ; 4 : 75–81. [PubMed] [Google Scholar]
  13. Diab A, Foca A, Fusil F, et al. Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication. Hepatology 2017 ; 66 : 1750–1765. [CrossRef] [PubMed] [Google Scholar]
  14. Gallucci L, Kann M. Nuclear Import of hepatitis B virus capsids and genome. Viruses 2017 ; 9. [Google Scholar]
  15. Faure-Dupuy S, Lucifora J, Durantel D. Interplay between the hepatitis B virus and innate immunity : from an understanding to the development of therapeutic concepts. Viruses 2017 ; 9. [Google Scholar]
  16. Zhang X, Lu W, Zheng Y, et al. In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection. J Clin Invest 2016 ; 126 : 1079–1092. [CrossRef] [PubMed] [Google Scholar]
  17. Bock CT, Schwinn S, Locarnini S, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol 2001 ; 307 : 183–196. [Google Scholar]
  18. Guo YH, Li YN, Zhao JR, et al. HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state. Epigenetics 2011 ; 6 : 720–726. [CrossRef] [PubMed] [Google Scholar]
  19. Belloni L, Li L, Palumbo GA, et al. HAPs hepatitis B virus (HBV) capsid inhibitors block core protein interaction with the viral minichromosome and host cell genes and affect cccDNA transcription and stability. Hepatol 2013 ; 58 : 277A. [Google Scholar]
  20. Zhang W, Chen J, Wu M, et al. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation. Hepatology 2017 ; 66 : 398–415. [CrossRef] [PubMed] [Google Scholar]
  21. Lubyova B, Hodek J, Zabransky A, et al. PRMT5 : a novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core. PLoS One 2017 ; 12 : e0186982. [CrossRef] [PubMed] [Google Scholar]
  22. Guo Y, Kang W, Lei X, et al. Hepatitis B viral core protein disrupts human host gene expression by binding to promoter regions. BMC Genomics 2012 ; 13 : 563. [CrossRef] [PubMed] [Google Scholar]
  23. Kwon JA, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells. Biol Chem 2003 ; 384 : 203–212. [PubMed] [Google Scholar]
  24. Du J, Liang X, Liu Y, et al. Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. Cell Death Differ 2009 ; 16 : 219–229. [CrossRef] [PubMed] [Google Scholar]
  25. Yang CC, Huang EY, Li HC, et al. Nuclear export of human hepatitis B virus core protein and pregenomic RNA depends on the cellular NXF1-p15 machinery. PLoS One 2014 ; 9 : e106683. [CrossRef] [PubMed] [Google Scholar]
  26. Rabe B, Delaleau M, Bischof A, et al. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog 2009 ; 5 : e1000563. [Google Scholar]
  27. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol 1992 ; 66 : 4107–4116. [PubMed] [Google Scholar]
  28. Wang XY, Wei ZM, Wu GY, et al. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations. Antivir Ther 2012 ; 17 : 793–803. [CrossRef] [PubMed] [Google Scholar]
  29. Bourne C, Lee S, Venkataiah B, et al. Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle. J Virol 2008 ; 82 : 10262–10270. [CrossRef] [PubMed] [Google Scholar]
  30. Guo F, Zhao Q, Sheraz M, et al. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways. PLoS Pathog 2017 ; 13 : e1006658. [CrossRef] [PubMed] [Google Scholar]
  31. Huber AD, Wolf JJ, Liu D, et al. The heteroaryldihydropyrimidine bay 38-7690 induces hepatitis B virus core protein aggregates associated with promyelocytic leukemia nuclear bodies in infected cells. mSphere 2018 ; 3. [Google Scholar]
  32. Lahlali T, Berke JM, Vergauwen K, et al. Novel potent capsid assembly modulators regulate multiple steps of the hepatitis B virus life-cycle. Antimicrob Agents Chemother 2018 Jul 16. pii: AAC.00835-18. doi: 10.1128/AAC.00835-18. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.